Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement | Cardiology | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Ostchega  Y, Fryar  C, Nwankwo  T, Nguyen  DT. Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017–2018. Published 2020. Accessed March 10, 2021. https://www.cdc.gov/nchs/products/databriefs/db364.htm
2.
Siu  AL; US Preventive Services Task Force.  Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement.   Ann Intern Med. 2015;163(10):778-786. doi:10.7326/M15-2223PubMedGoogle ScholarCrossref
3.
Procedure Manual. US Preventive Services Task Force. Published 2018. Accessed March 10, 2021. https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual
4.
Lewington  S, Clarke  R, Qizilbash  N, Peto  R, Collins  R; Prospective Studies Collaboration.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.   Lancet. 2002;360(9349):1903-1913. doi:10.1016/S0140-6736(02)11911-8PubMedGoogle ScholarCrossref
5.
Flint  AC, Conell  C, Ren  X,  et al.  Effect of systolic and diastolic blood pressure on cardiovascular outcomes.   N Engl J Med. 2019;381(3):243-251. doi:10.1056/NEJMoa1803180PubMedGoogle ScholarCrossref
6.
National High Blood Pressure Education Program.  The Seventh Report on the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health; 2004.
7.
Whelton  PK, Carey  RM, Aronow  WS,  et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.   Hypertension. 2018;71(6):e13-e115.PubMedGoogle Scholar
8.
Guirguis-Blake  JM, Evans  CV, Webber  EM, Coppola  EL, Perdue  LA, Weyrich  MS.  Screening for Hypertension in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 197. Agency for Healthcare Research and Quality; 2021. AHRQ publication 20-05265-EF-1.
9.
Guirguis-Blake  JM, Evans  CV, Webber  EM, Coppola  EL, Perdue  LA, Weyrich  MS.  Screening for hypertension in adults: updated evidence report and systematic review for the US Preventive Services Task Force.   JAMA. Published April 27, 2021. doi:10.1001/jama.2020.21669Google Scholar
10.
Benjamin  EJ, Blaha  MJ, Chiuve  SE,  et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  Heart disease and stroke statistics—2017 update: a report from the American Heart Association.   Circulation. 2017;135(10):e146-e603. doi:10.1161/CIR.0000000000000485PubMedGoogle ScholarCrossref
11.
James  PA, Oparil  S, Carter  BL,  et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).   JAMA. 2014;311(5):507-520. doi:10.1001/jama.2013.284427PubMedGoogle ScholarCrossref
12.
Curry  SJ, Krist  AH, Owens  DK,  et al; US Preventive Services Task Force.  Risk assessment for cardiovascular disease with nontraditional risk factors: US Preventive Services Task Force recommendation statement.   JAMA. 2018;320(3):272-280. doi:10.1001/jama.2018.8359PubMedGoogle ScholarCrossref
13.
Curry  SJ, Krist  AH, Owens  DK,  et al; US Preventive Services Task Force.  Screening for atrial fibrillation with electrocardiography: US Preventive Services Task Force recommendation statement.   JAMA. 2018;320(5):478-484. doi:10.1001/jama.2018.10321PubMedGoogle ScholarCrossref
14.
LeFevre  ML; US Preventive Services Task Force.  Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force recommendation statement.   Ann Intern Med. 2014;161(8):587-593. doi:10.7326/M14-1796PubMedGoogle ScholarCrossref
15.
Grossman  DC, Bibbins-Domingo  K, Curry  SJ,  et al; US Preventive Services Task Force.  Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement.   JAMA. 2017;318(2):167-174. doi:10.1001/jama.2017.7171PubMedGoogle ScholarCrossref
16.
Bibbins-Domingo  K, Grossman  DC, Curry  SJ,  et al; US Preventive Services Task Force.  Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.   JAMA. 2016;316(19):1997-2007. doi:10.1001/jama.2016.15450PubMedGoogle ScholarCrossref
17.
Bibbins-Domingo  K; US Preventive Services Task Force.  Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force recommendation statement.   Ann Intern Med. 2016;164(12):836-845. doi:10.7326/M16-0577PubMedGoogle ScholarCrossref
18.
Moyer  VA; US Preventive Services Task Force.  Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.   Ann Intern Med. 2013;159(9):613-619. doi:10.7326/0003-4819-159-9-201311050-00725PubMedGoogle ScholarCrossref
19.
Kaczorowski  J, Chambers  LW, Dolovich  L,  et al.  Improving cardiovascular health at population level: 39-community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP).   BMJ. 2011;342:d442. doi:10.1136/bmj.d442PubMedGoogle ScholarCrossref
20.
Pierdomenico  SD, Cuccurullo  F.  Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis.   Am J Hypertens. 2011;24(1):52-58. doi:10.1038/ajh.2010.203PubMedGoogle ScholarCrossref
21.
Briasoulis  A, Androulakis  E, Palla  M, Papageorgiou  N, Tousoulis  D.  White-coat hypertension and cardiovascular events: a meta-analysis.   J Hypertens. 2016;34(4):593-599. doi:10.1097/HJH.0000000000000832PubMedGoogle ScholarCrossref
22.
Huang  Y, Huang  W, Mai  W,  et al.  White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.   J Hypertens. 2017;35(4):677-688. doi:10.1097/HJH.0000000000001226PubMedGoogle ScholarCrossref
23.
Asayama  K, Thijs  L, Li  Y,  et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators.  Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population.   Hypertension. 2014;64(5):935-942. doi:10.1161/HYPERTENSIONAHA.114.03614PubMedGoogle ScholarCrossref
24.
Cohen  JB, Lotito  MJ, Trivedi  UK, Denker  MG, Cohen  DL, Townsend  RR.  Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis.   Ann Intern Med. 2019;170(12):853-862. doi:10.7326/M19-0223PubMedGoogle ScholarCrossref
25.
Shimbo  D, Muntner  P.  Should out-of-office monitoring be performed for detecting white coat hypertension?   Ann Intern Med. 2019;170(12):890-892. doi:10.7326/M19-1134PubMedGoogle ScholarCrossref
26.
Conen  D, Aeschbacher  S, Thijs  L,  et al.  Age-specific differences between conventional and ambulatory daytime blood pressure values.   Hypertension. 2014;64(5):1073-1079. doi:10.1161/HYPERTENSIONAHA.114.03957PubMedGoogle ScholarCrossref
27.
Wang  YC, Shimbo  D, Muntner  P, Moran  AE, Krakoff  LR, Schwartz  JE.  Prevalence of masked hypertension among US adults with nonelevated clinic blood pressure.   Am J Epidemiol. 2017;185(3):194-202. doi:10.1093/aje/kww237PubMedGoogle Scholar
28.
Muntner  P, Shimbo  D, Carey  RM,  et al.  Measurement of blood pressure in humans: a scientific statement from the American Heart Association.   Hypertension. 2019;73(5):e35-e66. doi:10.1161/HYP.0000000000000087PubMedGoogle ScholarCrossref
29.
Centers for Medicare & Medicaid Services. Decision Memo for Ambulatory Blood Pressure Monitoring (ABPM) (CAG-00067R2). Published 2019. Accessed March 10, 2021. https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=294
30.
Shimbo  D, Artinian  NT, Basile  JN,  et al; American Heart Association and the American Medical Association.  Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association.   Circulation. 2020;142(4):e42-e63. doi:10.1161/CIR.0000000000000803PubMedGoogle ScholarCrossref
31.
American Medical Association. US blood pressure validated device listing. Published 2021. Accessed March 10, 2021. https://www.validatebp.org
32.
American Academy of Family Physicians. Clinical Preventive Services Recommendation: hypertension. Accessed March 10, 2021. https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/hypertension.html
Views 33,028
Citations 0
US Preventive Services Task Force
Recommendation Statement
April 27, 2021

Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement

US Preventive Services Task Force
JAMA. 2021;325(16):1650-1656. doi:10.1001/jama.2021.4987
Abstract

Importance  Hypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardial infarction, stroke, and chronic kidney disease.

Objective  To reaffirm its 2015 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertension in adults, the accuracy of office blood pressure measurement for initial screening, and the accuracy of various confirmatory blood pressure measurement methods.

Population  Adults 18 years or older without known hypertension.

Evidence Assessment  Using a reaffirmation deliberation process, the USPSTF concludes with high certainty that screening for hypertension in adults has substantial net benefit.

Recommendation  The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement. The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment. (A recommendation)

×